Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: A retrospective review of CT scans and fasting glucose values prior to diagnosis

Mario Pelaez-Luna, Naoki Takahashi, Joel Garland Fletcher, Suresh T Chari

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

BACKGROUND: The timeline of progression of pancreatic cancer from resectable to unresectable disease is unknown. New-onset diabetes often occurs in pancreatic cancer. It is unclear if the cancer is resectable at the onset of diabetes. We (a) determined the resectability of pancreatic cancer on abdominal CT scans done prior to clinical diagnosis and (b) correlated resectability with onset of diabetes. METHODS: All CT scans done at diagnosis or before pancreatic cancer diagnosis were reviewed and pancreatic changes classified as normal, potentially resectable, or unresectable pancreatic cancer. Fasting blood glucose values obtained at and prior to diagnosis were available in 18 patients. The date of onset of diabetes and the interval between onset of diabetes and diagnosis of cancer were noted. RESULTS: Thirty patients fulfilled inclusion criteria. Prior to diagnosis, 28 patients had 38 CT scans done at a median of 18 months (range 1-41) before cancer diagnosis. At cancer diagnosis, only 7/30 patients could undergo margin-negative surgical resection. CT scans done ≥6 months prior to diagnosis showed either a normal pancreas (N = 20) or a resectable mass (N = 6); none had unresectable cancer. The mean interval between onset of diabetes and diagnosis of pancreatic cancer was 10 months (range 5-29 months). At the onset of diabetes, 3 patients had normal pancreas, 6 had resectable, and 4 had unresectable pancreatic cancer. CONCLUSIONS: Pancreatic cancer is frequently undetectable or resectable on CT scans done ≥6 months prior to clinical diagnosis. At onset of diabetes, pancreatic cancers are generally resectable.

Original languageEnglish (US)
Pages (from-to)2157-2163
Number of pages7
JournalAmerican Journal of Gastroenterology
Volume102
Issue number10
DOIs
StatePublished - Oct 2007

Fingerprint

Pancreatic Neoplasms
Fasting
Glucose
Neoplasms
Pancreas
Blood Glucose

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{7b3aacea85734d989c92a4156c8f20f9,
title = "Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: A retrospective review of CT scans and fasting glucose values prior to diagnosis",
abstract = "BACKGROUND: The timeline of progression of pancreatic cancer from resectable to unresectable disease is unknown. New-onset diabetes often occurs in pancreatic cancer. It is unclear if the cancer is resectable at the onset of diabetes. We (a) determined the resectability of pancreatic cancer on abdominal CT scans done prior to clinical diagnosis and (b) correlated resectability with onset of diabetes. METHODS: All CT scans done at diagnosis or before pancreatic cancer diagnosis were reviewed and pancreatic changes classified as normal, potentially resectable, or unresectable pancreatic cancer. Fasting blood glucose values obtained at and prior to diagnosis were available in 18 patients. The date of onset of diabetes and the interval between onset of diabetes and diagnosis of cancer were noted. RESULTS: Thirty patients fulfilled inclusion criteria. Prior to diagnosis, 28 patients had 38 CT scans done at a median of 18 months (range 1-41) before cancer diagnosis. At cancer diagnosis, only 7/30 patients could undergo margin-negative surgical resection. CT scans done ≥6 months prior to diagnosis showed either a normal pancreas (N = 20) or a resectable mass (N = 6); none had unresectable cancer. The mean interval between onset of diabetes and diagnosis of pancreatic cancer was 10 months (range 5-29 months). At the onset of diabetes, 3 patients had normal pancreas, 6 had resectable, and 4 had unresectable pancreatic cancer. CONCLUSIONS: Pancreatic cancer is frequently undetectable or resectable on CT scans done ≥6 months prior to clinical diagnosis. At onset of diabetes, pancreatic cancers are generally resectable.",
author = "Mario Pelaez-Luna and Naoki Takahashi and Fletcher, {Joel Garland} and Chari, {Suresh T}",
year = "2007",
month = "10",
doi = "10.1111/j.1572-0241.2007.01480.x",
language = "English (US)",
volume = "102",
pages = "2157--2163",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes

T2 - A retrospective review of CT scans and fasting glucose values prior to diagnosis

AU - Pelaez-Luna, Mario

AU - Takahashi, Naoki

AU - Fletcher, Joel Garland

AU - Chari, Suresh T

PY - 2007/10

Y1 - 2007/10

N2 - BACKGROUND: The timeline of progression of pancreatic cancer from resectable to unresectable disease is unknown. New-onset diabetes often occurs in pancreatic cancer. It is unclear if the cancer is resectable at the onset of diabetes. We (a) determined the resectability of pancreatic cancer on abdominal CT scans done prior to clinical diagnosis and (b) correlated resectability with onset of diabetes. METHODS: All CT scans done at diagnosis or before pancreatic cancer diagnosis were reviewed and pancreatic changes classified as normal, potentially resectable, or unresectable pancreatic cancer. Fasting blood glucose values obtained at and prior to diagnosis were available in 18 patients. The date of onset of diabetes and the interval between onset of diabetes and diagnosis of cancer were noted. RESULTS: Thirty patients fulfilled inclusion criteria. Prior to diagnosis, 28 patients had 38 CT scans done at a median of 18 months (range 1-41) before cancer diagnosis. At cancer diagnosis, only 7/30 patients could undergo margin-negative surgical resection. CT scans done ≥6 months prior to diagnosis showed either a normal pancreas (N = 20) or a resectable mass (N = 6); none had unresectable cancer. The mean interval between onset of diabetes and diagnosis of pancreatic cancer was 10 months (range 5-29 months). At the onset of diabetes, 3 patients had normal pancreas, 6 had resectable, and 4 had unresectable pancreatic cancer. CONCLUSIONS: Pancreatic cancer is frequently undetectable or resectable on CT scans done ≥6 months prior to clinical diagnosis. At onset of diabetes, pancreatic cancers are generally resectable.

AB - BACKGROUND: The timeline of progression of pancreatic cancer from resectable to unresectable disease is unknown. New-onset diabetes often occurs in pancreatic cancer. It is unclear if the cancer is resectable at the onset of diabetes. We (a) determined the resectability of pancreatic cancer on abdominal CT scans done prior to clinical diagnosis and (b) correlated resectability with onset of diabetes. METHODS: All CT scans done at diagnosis or before pancreatic cancer diagnosis were reviewed and pancreatic changes classified as normal, potentially resectable, or unresectable pancreatic cancer. Fasting blood glucose values obtained at and prior to diagnosis were available in 18 patients. The date of onset of diabetes and the interval between onset of diabetes and diagnosis of cancer were noted. RESULTS: Thirty patients fulfilled inclusion criteria. Prior to diagnosis, 28 patients had 38 CT scans done at a median of 18 months (range 1-41) before cancer diagnosis. At cancer diagnosis, only 7/30 patients could undergo margin-negative surgical resection. CT scans done ≥6 months prior to diagnosis showed either a normal pancreas (N = 20) or a resectable mass (N = 6); none had unresectable cancer. The mean interval between onset of diabetes and diagnosis of pancreatic cancer was 10 months (range 5-29 months). At the onset of diabetes, 3 patients had normal pancreas, 6 had resectable, and 4 had unresectable pancreatic cancer. CONCLUSIONS: Pancreatic cancer is frequently undetectable or resectable on CT scans done ≥6 months prior to clinical diagnosis. At onset of diabetes, pancreatic cancers are generally resectable.

UR - http://www.scopus.com/inward/record.url?scp=34848828966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848828966&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2007.01480.x

DO - 10.1111/j.1572-0241.2007.01480.x

M3 - Article

C2 - 17897335

AN - SCOPUS:34848828966

VL - 102

SP - 2157

EP - 2163

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 10

ER -